Moderate Alcohol Intake and Lower Risk of Coronary Heart Disease: Meta-analysis of Effects on Lipids and Haemostatic Factors

Overview

Journal BMJ

Specialty General Medicine

Date 1999 Dec 11

PMID 10591709

Citations 325

Authors

E B Rimm

P Williams

K Fosher

M Criqui

M J Stampfer

Affiliations

Soon will be listed here.

Abstract

Objective: To summarise quantitatively the association between moderate alcohol intake and biological markers of risk of coronary heart disease and to predict how these changes would lower the risk.

Design: Meta-analysis of all experimental studies that assessed the effects of moderate alcohol intake on concentrations of high density lipoprotein cholesterol, apolipoprotein A I, fibrinogen, triglycerides, and other biological markers previously found to be associated with risk of coronary heart disease.

Participants: Men and women free of previous chronic disease and who were not dependent on alcohol. Studies were included in which biomarkers were assessed before and after participants consumed up to 100 g of alcohol a day.

Interventions: Alcohol as ethanol, beer, wine, or spirits.

Main Outcome Measures: Changes in concentrations of high density lipoprotein cholesterol, apolipoprotein A I, Lp(a) lipoprotein, triglycerides, tissue type plasminogen activator activity, tissue type plasminogen activator antigen, insulin, and glucose after consuming an experimental dose of alcohol for 1 to 9 weeks; a shorter period was accepted for studies of change in concentrations of fibrinogen, factor VII, von Willebrand factor, tissue type plasminogen activator activity, and tissue type plasminogen activator antigen.

Results: 61 data records were abstracted from 42 eligible studies with information on change in biological markers of risk of coronary heart disease. An experimental dose of 30 g of ethanol a day increased concentrations of high density lipoprotein cholesterol by 3.99 mg/dl (95% confidence interval 3.25 to 4.73), apolipoprotein A I by 8.82 mg/dl (7.79 to 9.86), and triglyceride by 5.69 mg/dl (2.49 to 8.89). Several haemostatic factors related to a thrombolytic profile were modestly affected by alcohol. On the basis of published associations between these biomarkers and risk of coronary heart disease 30 g of alcohol a day would cause an estimated reduction of 24.7% in risk of coronary heart disease.

Conclusions: Alcohol intake is causally related to lower risk of coronary heart disease through changes in lipids and haemostatic factors.

Citing Articles

Lipid Profiles After Changes in Alcohol Consumption Among Adults Undergoing Annual Checkups.

Suzuki T, Fukui S, Shinozaki T, Asano T, Yoshida T, Aoki J JAMA Netw Open. 2025; 8(3):e250583.

PMID: 40072433 PMC: 11904732. DOI: 10.1001/jamanetworkopen.2025.0583.

2024 The Royal College of Physicians of Thailand (RCPT) clinical practice guidelines on management of dyslipidemia for atherosclerotic cardiovascular disease prevention.

Lolekha P, Khovidhunkit W, Deerochanawong C, Thongtang N, Boonyasirinant T, Rattarasarn C Asian Biomed (Res Rev News). 2024; 18(6):246-267.

PMID: 39697215 PMC: 11650434. DOI: 10.2478/abm-2024-0033.

Assessing alcohol consumption across phosphatidylethanol levels using HDL-cholesterol as a predictor.

Arving A, Hilberg T, Vigerust E, Jorgenrud B, Bogstrand S, Morland J Alcohol Alcohol. 2024; 60(1).

PMID: 39671567 PMC: 11642604. DOI: 10.1093/alcalc/agae085.

Association of alcohol consumption with aortic aneurysm and dissection risk: results from the UK Biobank cohort study.

Liang Y, Zou G, Wang D, Zeng W, Zhang J, Huang X World J Emerg Med. 2024; 15(6):465-474.

PMID: 39600819 PMC: 11586140. DOI: 10.5847/wjem.j.1920-8642.2024.096.

Impact of Alcohol Consumption on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention.

Yun J, Han K, Ki Y, Hwang D, Kang J, Yang H J Clin Med. 2024; 13(21).

PMID: 39518680 PMC: 11546366. DOI: 10.3390/jcm13216542.

References

Savolainen M, Kesaniemi Y . Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol. 1995; 6(4):243-50. DOI: 10.1097/00041433-199508000-00009. View

Smith S, Caudill S, Steinberg K, Thacker S . On combining dose-response data from epidemiological studies by meta-analysis. Stat Med. 1995; 14(5-7):531-44. DOI: 10.1002/sim.4780140513. View

Renaud S, Ruf J . Effects of alcohol on platelet functions. Clin Chim Acta. 1996; 246(1-2):77-89. DOI: 10.1016/0009-8981(96)06228-6. View

Stampfer M, Krauss R, Ma J, Blanche P, Holl L, Sacks F . A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996; 276(11):882-8. View

Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M . Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996; 313(7064):1040-4. PMC: 2352363. DOI: 10.1136/bmj.313.7064.1040. View

Branchi A, Rovellini A, Tomella C, Sciariada L, Torri A, Molgora M . Association of alcohol consumption with HDL subpopulations defined by apolipoprotein A-I and apolipoprotein A-II content. Eur J Clin Nutr. 1997; 51(6):362-5. DOI: 10.1038/sj.ejcn.1600408. View

Criqui M . Alcohol and coronary heart disease risk: implications for public policy. J Stud Alcohol. 1997; 58(5):453-4. DOI: 10.15288/jsa.1997.58.453. View

Klatsky A, Armstrong M, Friedman G . Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am J Cardiol. 1997; 80(4):416-20. DOI: 10.1016/s0002-9149(97)00388-3. View

Rehm J, Bondy S, Sempos C, Vuong C . Alcohol consumption and coronary heart disease morbidity and mortality. Am J Epidemiol. 1997; 146(6):495-501. DOI: 10.1093/oxfordjournals.aje.a009303. View

10.

Thun M, Peto R, Lopez A, Monaco J, Henley S, Heath Jr C . Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997; 337(24):1705-14. DOI: 10.1056/NEJM199712113372401. View

11.

DOLL R . One for the heart. BMJ. 1998; 315(7123):1664-8. PMC: 2128014. DOI: 10.1136/bmj.315.7123.1664. View

12.

Furman M, Benoit S, Barnard M, Valeri C, Borbone M, Becker R . Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol. 1998; 31(2):352-8. DOI: 10.1016/s0735-1097(97)00510-x. View

13.

Smith-Warner S, Spiegelman D, Yaun S, van den Brandt P, Folsom A, Goldbohm R . Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998; 279(7):535-40. DOI: 10.1001/jama.279.7.535. View

14.

Meade T, Chakrabarti R, Haines A, North W, Stirling Y . Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979; 1(6157):153-6. PMC: 1597599. DOI: 10.1136/bmj.1.6157.153. View

15.

Rosenberg L, Slone D, Shapiro S, Kaufman D, Miettinen O, STOLLEY P . Alcoholic beverages and myocardial infarction in young women. Am J Public Health. 1981; 71(1):82-5. PMC: 1619716. DOI: 10.2105/ajph.71.1.82. View

16.

Puddey I, Beilin L, VANDONGEN R, Rouse I, Rogers P . Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial. Hypertension. 1985; 7(5):707-13. DOI: 10.1161/01.hyp.7.5.707. View

17.

Moore R, PEARSON T . Moderate alcohol consumption and coronary artery disease. A review. Medicine (Baltimore). 1986; 65(4):242-67. DOI: 10.1097/00005792-198607000-00004. View

18.

Friedman L, Kimball A . Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol. 1986; 124(3):481-9. DOI: 10.1093/oxfordjournals.aje.a114418. View

19.

Meade T, Mellows S, Brozovic M, Miller G, Chakrabarti R, North W . Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986; 2(8506):533-7. DOI: 10.1016/s0140-6736(86)90111-x. View

20.

Meade T, Imeson J, Stirling Y . Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 1987; 2(8566):986-8. DOI: 10.1016/s0140-6736(87)92556-6. View